Literature DB >> 21152564

Antibody engineering toward high-sensitivity high-throughput immunosensing of small molecules.

Norihiro Kobayashi1, Hiroyuki Oyama.   

Abstract

Clinical and environmental analyses often require immunochemical detection and quantification of small molecules (haptens) that are available as biomarkers. However, the affinity ceilings of conventional anti-hapten antibodies, which are produced by immunizing animals, prevent subfemtomole-range determinations with competitive immunoassay formats. "Sandwich-type" noncompetitive (immunometric) assays allow for sensitive determinations of macromolecules (subattomole-range) and the direct relationship between analyte amount and signal intensity provides higher accessibility to modern high-throughput sensing systems. Unfortunately, sandwich-type assays require that analytes have at least two epitopes, and thus are not applicable to haptens. Antibody engineering, i.e., genetic manipulation of antibody molecules, could provide artificially improved reagents that enable us to overcome these limitations. In this review, we summarize recent successful developments and applications of engineered antibodies for sensitive and high-throughput hapten sensing.

Mesh:

Substances:

Year:  2010        PMID: 21152564     DOI: 10.1039/c0an00603c

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  8 in total

Review 1.  Molecular engineering of antibodies for therapeutic and diagnostic purposes.

Authors:  Frédéric Ducancel; Bruno H Muller
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

Review 2.  Chromatographic immunoassays: strategies and recent developments in the analysis of drugs and biological agents.

Authors:  Ryan Matsuda; Elliott Rodriguez; Doddavenkatanna Suresh; David S Hage
Journal:  Bioanalysis       Date:  2015-11-16       Impact factor: 2.681

Review 3.  Klotho: An Elephant in Aging Research.

Authors:  Amin Cheikhi; Aaron Barchowsky; Amrita Sahu; Sunita N Shinde; Abish Pius; Zachary J Clemens; Hua Li; Charles A Kennedy; Joerg D Hoeck; Michael Franti; Fabrisia Ambrosio
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-06-18       Impact factor: 6.053

4.  Different expression systems resulted in varied binding properties of anti-paclitaxel single-chain variable fragment antibody clone 1C2.

Authors:  Gorawit Yusakul; Seiichi Sakamoto; Poomraphie Nuntawong; Hiroyuki Tanaka; Satoshi Morimoto
Journal:  J Nat Med       Date:  2017-10-12       Impact factor: 2.343

5.  Shiga-like toxin B subunit of Escherichia coli as scaffold for high-avidity display of anti-immunocomplex peptides.

Authors:  Gabriel Lassabe; Martín Rossotti; Andrés González-Techera; Gualberto González-Sapienza
Journal:  Anal Chem       Date:  2014-05-21       Impact factor: 6.986

6.  The VH framework region 1 as a target of efficient mutagenesis for generating a variety of affinity-matured scFv mutants.

Authors:  Yuki Kiguchi; Hiroyuki Oyama; Izumi Morita; Yasuhiro Nagata; Naoko Umezawa; Norihiro Kobayashi
Journal:  Sci Rep       Date:  2021-04-15       Impact factor: 4.379

7.  Clonal array profiling of scFv-displaying phages for high-throughput discovery of affinity-matured antibody mutants.

Authors:  Yuki Kiguchi; Hiroyuki Oyama; Izumi Morita; Mai Morikawa; Asuka Nakano; Wakana Fujihara; Yukari Inoue; Megumi Sasaki; Yuki Saijo; Yuki Kanemoto; Kaho Murayama; Yuki Baba; Atsuko Takeuchi; Norihiro Kobayashi
Journal:  Sci Rep       Date:  2020-08-24       Impact factor: 4.379

8.  Seeking high-priority mutations enabling successful antibody-breeding: systematic analysis of a mutant that gained over 100-fold enhanced affinity.

Authors:  Hiroyuki Oyama; Yuki Kiguchi; Izumi Morita; Chika Yamamoto; Yuka Higashi; Miku Taguchi; Tatsuya Tagawa; Yuri Enami; Yuriko Takamine; Hanako Hasegawa; Atsuko Takeuchi; Norihiro Kobayashi
Journal:  Sci Rep       Date:  2020-03-16       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.